Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function
2021 · Cellular and Molecular Immunology · 45 citations
https://doi.org/10.1038/s41423-020-00601-8